Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2021	Mar. 31, 2021
ASSETS
Cash and cash equivalents	$ 7,417	$ 8,195
Restricted cash and cash equivalents	3,322	1,957
Investments in marketable securities	4,843	4,820
Finance receivables, net of allowance for credit losses of $1,147 and $1,178	78,500	79,192
Investments in operating leases, net	37,784	37,091
Other assets	2,535	2,473
Total assets	134,401	133,728
LIABILITIES AND SHAREHOLDER’S EQUITY
Debt	109,133	109,725
Deferred income taxes	2,638	2,860
Other liabilities	6,105	5,548
Total liabilities	117,876	118,133
Commitments and contingencies (Refer to Note 9)
Shareholder’s equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at June 30, 2021 and March 31, 2021	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive income	17	8
Retained earnings	15,591	14,670
Total shareholder's equity	16,525	15,595
Total liabilities and shareholder's equity	$ 134,401	$ 133,728